Position in RNA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,150,466
New position
Shares Held
235,637
first reported quarter
Ownership
1.38%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026CANTOR FITZGERALD, L. P. holds $25,602,427 across 21 Biotechnology names. RNA ranks #2 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IMCR |
Immunocore Holdings plc
|
250,211 | $7,543,861 | |
| 2 | RNA |
Atrium Therapeutics, Inc.
This page
|
235,637 | $3,150,466 | |
| 3 | CABA |
Cabaletta Bio, Inc.
|
765,000 | $2,057,850 | |
| 4 | VSTM |
Verastem, Inc.
|
363,132 | $1,924,599 | |
| 5 | INSM |
INSMED Inc
|
11,000 | $1,798,720 | |
| 6 | ACOG |
Alpha Cognition Inc.
|
188,631 | $1,035,584 | |
| 7 | SLNO |
Soleno Therapeutics Inc
|
30,000 | $1,004,400 | |
| 8 | RCUS |
Arcus Biosciences, Inc.
|
45,000 | $972,000 |
All Filings in RNA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,150,466 | 235,637 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||